![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7dcc9f90.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7dd99934.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7de4473e.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7dee683f.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7df8e0cd.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7e02d543.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7e0f35b7.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7e19e80f.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ebf7e2452a6.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/details_thumb/61ed38767e188.20220123.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7dcc9f90.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7dd99934.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7de4473e.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7dee683f.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7df8e0cd.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7e02d543.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7e0f35b7.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7e19e80f.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ebf7e2452a6.20220122.png)
![Product Image](https://www.skfbd.com/uploads/medicine/listing_thumb/61ed38767e188.20220123.png)
Vigamet
DESCRIPTION
Vigamet® is a combined preparation of two antihyperglycemic agents with different mechanisms of action to improve glycaemic control in patients
with type 2 diabetes: Vildagliptin, a member of the DPP-4 (dipeptidyl-peptidase- 4) inhibitor class and Metformin Hydrochloride, a member of the biguanide class. Vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (DPP-4) inhibitor that improves glycaemic control. Metformin Hydrochloride improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin Hydrochloride decreases hepatic glucose production, decrease intestinal absorption of glucose and improves insulin